Catalyst Wire Dossier Catalyst Wire Dossier

CARBOPLATIN

Carboplatin · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

1148 regulatory and trial events tracked for CARBOPLATIN, covering 2006-07-19 to 2026-06-17. Get the full timeline:

Most recent: Clinical Trial Results: Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer [Phase 2]

See pricing